May 2025 in numbers
NHS community prescribing in England (Prescription Cost Analysis).
107,888,893items
Dispensed in May 2025
NHSBSA Prescription Cost Analysis
£953,615,777
Net ingredient cost, May 2025
NHSBSA PCA
Most-dispensed medicines
Download full month (CSV)| Medicine | Items | Net ingredient cost |
|---|---|---|
| Atorvastatin | 6,496,689 | £6,594,750 |
| Amlodipine | 3,488,236 | £3,054,238 |
| Lansoprazole | 3,173,979 | £4,030,480 |
| Ramipril | 3,066,113 | £3,409,514 |
| Omeprazole | 3,042,873 | £8,532,502 |
| Levothyroxine sodium | 2,962,650 | £3,908,464 |
| Bisoprolol fumarate | 2,619,523 | £2,044,621 |
| Colecalciferol | 2,448,144 | £9,928,365 |
| Metformin hydrochloride | 2,307,589 | £7,332,431 |
| Sertraline hydrochloride | 2,142,146 | £4,122,987 |
| Aspirin | 1,719,248 | £1,280,037 |
| Salbutamol | 1,485,910 | £4,564,842 |
Biggest risers
Largest month-on-month rise in items (medicines above 10,000 items).
| Medicine | Items | Change |
|---|---|---|
| Norethisterone | 32,496 | +24.3% |
| Fluconazole | 56,691 | +22.5% |
| Naftidrofuryl oxalate | 12,507 | +20.6% |
| Amorolfine hydrochloride | 15,080 | +16.0% |
| Medroxyprogesterone acetate | 23,063 | +14.8% |
| Other individually formulated bought in preparations | 23,363 | +12.3% |
| Tirzepatide | 206,101 | +12.3% |
| Diclofenac sodium | 31,677 | +12.2% |
Biggest fallers
Largest month-on-month fall in items.
| Medicine | Items | Change |
|---|---|---|
| Nystatin | 44,156 | −30.6% |
| Amoxicillin | 600,088 | −11.7% |
| Influenza | 71,655 | −11.3% |
| Doxycycline hyclate | 294,727 | −10.5% |
| Chloramphenicol | 73,106 | −8.2% |
| Phenoxymethylpenicillin (Penicillin V) | 231,512 | −6.8% |
| Permethrin | 18,788 | −6.8% |
| Clarithromycin | 146,189 | −6.1% |